Manulife (Manufacturers Life Insurance)
AVBP icon

Manulife (Manufacturers Life Insurance)’s ArriVent BioPharma AVBP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Buy
+9,068
New +$205K ﹤0.01% 2452
2025
Q2 		– Sell
-10,404
Closed -$192K – 3015
2025
Q1 		$192K Buy
10,404
+386
+4% +$9.45K ﹤0.01% 2509
2024
Q4 		$267K Sell
10,018
-216
-2% -$6.2K ﹤0.01% 2505
2024
Q3 		$240K Buy
+10,234
New +$232K ﹤0.01% 2581

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s AVBP Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in ArriVent BioPharma (AVBP) in Q1 2026: 9,068 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in AVBP as recently as Q1 2025.

Manulife (Manufacturers Life Insurance) first reported a position in AVBP in Q3 2024 and has held it in 4 quarters since. The position peaked at $267K in Q4 2024. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 9,068 shares of ArriVent BioPharma worth $209K as of Q1 2026.
  • ArriVent BioPharma was a new Manulife (Manufacturers Life Insurance) position in Q1 2026.
  • ArriVent BioPharma made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2452 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in ArriVent BioPharma in Q3 2024 and has held it in 4 quarters since.
  • Manulife (Manufacturers Life Insurance)'s ArriVent BioPharma position peaked at $267K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.